Alex - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

inda: I'd like to introduce Alex from England. You take LDN for Multiple Sclerosis. Thank you for joining me, Alex. 

Alex: You're welcome. 

Linda: Could you tell me when have you been diagnosed with Ms?

Alan - England: Multiple Sclerosis; MS (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda: I would like to introduce Alan from England. Alan has multiple sclerosis.

Alan: Hello. Could you tell us when you first started getting ms symptoms?

Adrienne - England: Multiple Sclerosis; MS (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda: I'd like to introduce Adrienne who has multiple sclerosis and is from England. Welcome, Adrienne. 

Adrienne: Good morning.

Adam - US: Multiple Sclerosis(LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Adam: Hi, Linda. 

Linda: Could you tell us when you first started to notice MS symptoms? 

Shirin from England shares her Multiple Sclerosis (MS) & Low Dose Naltrexone (LDN) Story from LDN Research Trust on Vimeo.

Shirin from England was diagnosed with Multiple Sclerosis (MS) in 2008 after experiencing poor balance, bladder control, fatigue, memory issues, weakness and trouble walking the previous year.

Linda Elsegood - The LDN Research Trust 14 Oct 2020 (Low dose naltrexone) from LDN Research Trust on Vimeo.

Part of the LDN Book 2 Tour with Motivated Medicine and Mark Drugs

Low-Dose Naltrexone for Fibromyalgia and ME/CFS

Verywell Health
04 November 2020
https://www.verywellhealth.com/low-dose-naltrexone-ldn-for-fibromyalgia-cfs-716070

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

Calls for the radical treatment

The Irish Times
04 Mar 2021
https://www.irishtimes.com/news/health/calls-for-the-radical-treatment-1.1140972

Nutrichem's LDN Book Events with Linda Elsegood (Low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Book Volume 2 & The Goals of the LDN Research Trust